HP and Intel see potential in the life sciences market

  • Business
  • Thursday, 05 Jun 2003


HEWLETT Packard Sales (M) Sdn Bhd and Intel Electronics (M) Sdn Bhd are looking at the US$2.6bil revenue potential of the Asia Pacific life sciences industry to drive their business growth in the region.  

Both the major information technology (IT) players are looking at partnerships with life sciences researchers and developers to strengthen the performance of their products.  

HP country business manager for business critical systems, enterprise systems group Raymond Victor, and Intel Malaysia country manager Peter Choong, expressed optimism on the outlook of the sector at a press conference in Kuala Lumpur yesterday.  

From left to right: Abdul Karim Hercus, managing director, Synamatix Sdn Bhd, Raymond Victor, country business manager, business critical systems, enterprise systems group, Hewlett-Packard Sales (Malaysia) Sdn Bhd and Peter Choong, country manager of Intel Electronics (M) Sdn Bhd

HP had earlier announced a partnership with local bioinformatics company Synamatix Sdn Bhd (Synamatix), which claimed to have created the world's first bioinformatics software, SynaSuite, running on Linux on an HP platform powered by Intel's Itanium 2 processor.  

HP and Intel see demand for Itanium servers, IT products and chip processors picking up speed as more players enter the biotech industry, which requires super fast computing. 

International Data Corp (IDC) estimates the Asia Pacific life sciences market to grow at a compounded 46%, with funding injection of US$50bil from both public and private sources. 

Synamatix managing director Abdul Karim Hercus, said he expected SynaSuite to create a “major impact” in the growing biotech industries in Europe, Japan and the US by January next year.  

Potential clients would include universities, state governments and server providers. 

“We are in the process of filing our patent,” he said, adding that it would take about 18 months to receive the patent. Synamatix will participate at the Genetics Congress in Melbourne in mid-July, which would be attended by the who's who in the medical field, including Dr James D. Watson, who discovered the structure of DNA.  

Stakeholders in Synamatix are Neuramatix Sdn Bhd, 80% interest, local technology venture firm FirstFloor Capital (10%), and an unnamed offshore company (10%). 

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

Geely's Volvo Cars sets IPO price range, seeking up to US$23bil valuation
Inari signs MoU with a private equity fund in China to expand OSAT business
ES Ceramic posts strong Q1 growth
Southern Cable bags RM18.5mil TNB contract
Sunway Malls to launch Sunway eMall.com to boost presence
MIDA, MEDEF ink MoU on collaborative efforts
Car sales revved up in September as curbs lifted
German-based H&R to invest RM200mil in speciality plant in Perak
IOI Investment offers to purchase US$600m debt notes
Straits Energy Resources unit to acquire RM14.5mil oil tanker

Others Also Read